Covid-19: Zydus Cadila gets DGCI nod for phase 3 clinical trials with biological therapy
Published
Published
As India awaits with bated breath for a silver bullet against coronavirus, the Drug Controller General of India (DCGI) on Thursday..
The trials, which will commence in December.